Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[AP-HM tumour tissue bank: molecular signature of gliomas].
Figarella-Branger D, Colin C, Chinot O, Nanni I, Baeza N, Fina F, Tong S, Eudes N, Quilichini B, Romain S, Metellus P, Fuentes S, Barrié M, Boucard C, Fraslon C, Bonavita MJ, Martin PM, Ouafik L. Figarella-Branger D, et al. Among authors: ouafik l. Med Sci (Paris). 2006 Jan;22 Spec No 1:54-9. doi: 10.1051/medsci/2006221s54. Med Sci (Paris). 2006. PMID: 16705945 Free article. Review. French.
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
Chinot OL, Barrié M, Fuentes S, Eudes N, Lancelot S, Metellus P, Muracciole X, Braguer D, Ouafik L, Martin PM, Dufour H, Figarella-Branger D. Chinot OL, et al. Among authors: ouafik l. J Clin Oncol. 2007 Apr 20;25(12):1470-5. doi: 10.1200/JCO.2006.07.4807. J Clin Oncol. 2007. PMID: 17442989 Clinical Trial.
Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice.
Kaafarani I, Fernandez-Sauze S, Berenguer C, Chinot O, Delfino C, Dussert C, Metellus P, Boudouresque F, Mabrouk K, Grisoli F, Figarella-Branger D, Martin PM, Ouafik L. Kaafarani I, et al. Among authors: ouafik l. FASEB J. 2009 Oct;23(10):3424-35. doi: 10.1096/fj.08-127852. Epub 2009 Jun 22. FASEB J. 2009. PMID: 19546305
Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma.
Deville JL, Bartoli C, Berenguer C, Fernandez-Sauze S, Kaafarani I, Delfino C, Fina F, Salas S, Muracciole X, Mancini J, Lechevallier E, Martin PM, Figarella-Branger D, Ouafik L, Daniel L. Deville JL, et al. Among authors: ouafik l. Int J Cancer. 2009 Nov 15;125(10):2307-15. doi: 10.1002/ijc.24568. Int J Cancer. 2009. PMID: 19610056
Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
Metellus P, Coulibaly B, Nanni I, Fina F, Eudes N, Giorgi R, Barrie M, Chinot O, Fuentes S, Dufour H, Ouafik L, Figarella-Branger D. Metellus P, et al. Among authors: ouafik l. Cancer. 2009 Oct 15;115(20):4783-94. doi: 10.1002/cncr.24546. Cancer. 2009. PMID: 19637364 Free article.
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
Colin C, Voutsinos-Porche B, Nanni I, Fina F, Metellus P, Intagliata D, Baeza N, Bouvier C, Delfino C, Loundou A, Chinot O, Lah T, Kos J, Martin PM, Ouafik L, Figarella-Branger D. Colin C, et al. Among authors: ouafik l. Acta Neuropathol. 2009 Dec;118(6):745-54. doi: 10.1007/s00401-009-0592-2. Epub 2009 Sep 23. Acta Neuropathol. 2009. PMID: 19774387
165 results